Leaflet INNOHEP 10000UI ANTI-XA/ml solution for injection in vial

Indicated for: prevention and treatment of thromboembolism

Route of administration: injectable

Substance: tinzaparin (anticoagulant)

ATC: B01AB10 (Blood and blood forming organs | Antithrombotic agents | Heparin group)

Precautions:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk

This medicine may increase the risk of bleeding.

Tinzaparin is a low molecular weight heparin anticoagulant used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It works by inhibiting clotting factors, reducing the risk of blood clot formation.

The medication is administered as subcutaneous injections, as directed by a doctor. The dosage is adjusted based on the patient's weight and clinical condition.

Patients should be closely monitored to detect potential side effects, such as bleeding, injection site hematomas, or allergic reactions. It is important for patients to inform their doctor of any unusual symptoms.

Common side effects include bleeding, pain at the injection site, and elevated liver enzymes. In rare cases, severe reactions such as heparin-induced thrombocytopenia may occur. Patients should be informed of these risks before starting treatment.

General data about INNOHEP 10000UI ANTI-XA/ml

Substance: tinzaparin
Date of latest medicines list: 01-06-2026
Product code: W59473001
Concentration: 10000UI anti-XA / ml
Pharmaceutical form: solution for injection in vial
Packing volume: 2 ml
Product type: Original
Price: 590.98 RON
Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer: VIANEX S.A. - PLANT A - GRECIA
Holder: LEO PHARMA A/S - DANEMARCA
Number: 5234/2012/01
Shelf life: 2 years-after packing for marketing;after the first opening of the bottle-max. 14 days

Pharmaceutical forms available for tinzaparin

Concentrations available for tinzaparin

10000 U-AXa/ml
10000u ANTIF. Xa/ml
10000UI anti-XA/ml
20000 U-AXa/ml
20000 UI anti-Xa/ml
20000u ANTIF. Xa/ml
20000UI anti-Xa/ml

Compensation lists for INNOHEP 10000UI ANTI-XA/ml LEO Pharma

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

590.98 RON

172.42 RON

418.56 RON

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure